Compounds > nisoxetine

nisoxetine and 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine

nisoxetine has been researched along with 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Billes, SK; Cowley, MA2

Other Studies

2 other study(ies) available for nisoxetine and 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine

ArticleYear
Inhibition of dopamine and norepinephrine reuptake produces additive effects on energy balance in lean and obese mice.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:4

    Topics: Animals; Behavior, Animal; Body Weight; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Eating; Energy Metabolism; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Motor Activity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Obesity; Piperazines; Time Factors

2007
Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:6

    Topics: Animals; Area Under Curve; Behavior, Animal; Bupropion; Catecholamines; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Norepinephrine; Norethandrolone; Piperazines; Telemetry; Thermogenesis; Time Factors; Weight Loss

2008